HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Markus Hutterer Selected Research

Acquired Immunodeficiency Syndrome (AIDS)

12/2017AIDS-Related Central Nervous System Toxoplasmosis With Increased 18F-Fluoroethyl-L-Tyrosine Amino Acid PET Uptake Due to LAT1/2 Expression of Inflammatory Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Markus Hutterer Research Topics

Disease

17Glioma (Gliomas)
06/2022 - 06/2006
9Neoplasms (Cancer)
03/2024 - 01/2008
4Brain Neoplasms (Brain Tumor)
06/2022 - 03/2013
4Glioblastoma (Glioblastoma Multiforme)
03/2016 - 01/2014
3Neoplasm Metastasis (Metastasis)
04/2018 - 08/2008
2Disease Progression
06/2015 - 05/2014
1Oligodendroglioma
06/2022
1Astrocytoma (Pilocytic Astrocytoma)
06/2022
1Movement Disorders (Movement Disorder)
08/2021
1Lymphoma (Lymphomas)
07/2019
1Cerebral Hemorrhage
01/2019
1Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells
01/2019
1Acquired Immunodeficiency Syndrome (AIDS)
12/2017
1Cerebral Toxoplasmosis
12/2017
1Seizures (Absence Seizure)
01/2017
1Status Epilepticus (Complex Partial Status Epilepticus)
01/2017
1Hypertension (High Blood Pressure)
03/2016
1Ischemia
03/2014
1Brain Edema (Cerebral Edema)
04/2013
1Melanoma (Melanoma, Malignant)
08/2008
1Ovarian Neoplasms (Ovarian Cancer)
08/2008

Drug/Important Bio-Agent (IBA)

4Amino AcidsFDA Link
12/2017 - 01/2014
4Tyrosine (L-Tyrosine)FDA Link
12/2017 - 03/2013
3Proteins (Proteins, Gene)FDA Link
06/2018 - 01/2008
3LigandsIBA
06/2018 - 01/2008
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2022 - 11/2020
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2018 - 01/2008
2(18F)fluoroethyltyrosineIBA
12/2017 - 01/2017
2Temozolomide (Temodar)FDA LinkGeneric
03/2016 - 04/2015
2Bevacizumab (Avastin)FDA Link
03/2016 - 05/2014
1Protons (Proton)IBA
06/2022
1alpha-hydroxyglutarateIBA
11/2020
1Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2020
1Inositol (Myoinositol)IBA
11/2020
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
01/2019
1Serotonin (5 Hydroxytryptamine)IBA
01/2019
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2019
168Ga-pentixaforIBA
04/2018
1UbiquitinIBA
04/2018
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
01/2017
1Valproic Acid (Depakote)FDA LinkGeneric
03/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2016
1Neoplasm Antigens (Tumor Antigens)IBA
03/2016
1Biomarkers (Surrogate Marker)IBA
06/2015
1Prostaglandins BIBA
05/2014
1Retinaldehyde (Retinal)IBA
03/2014
1alovudineIBA
01/2014
1tyrosine receptor (receptor, tyrosine)IBA
01/2014
1Phosphotransferases (Kinase)IBA
01/2014
1Sunitinib (Sutent)FDA Link
01/2014
1NucleosidesIBA
01/2014
12-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA
01/2011
1TabletsIBA
01/2011
1Monoclonal AntibodiesIBA
08/2008
1Neuregulin-1 (Neuregulin 1)IBA
08/2008
1ErbB Receptors (EGF Receptor)IBA
08/2008
1ElementsIBA
01/2008
1Messenger RNA (mRNA)IBA
01/2008
1ParaffinIBA
01/2008

Therapy/Procedure

7Therapeutics
03/2024 - 06/2006
2Immunotherapy
08/2021 - 07/2019
2Radiotherapy
03/2016 - 04/2013
1Palliative Care (Palliative Therapy)
11/2019
1Combined Modality Therapy
06/2015
1Chemoradiotherapy
04/2015
1Drug Therapy (Chemotherapy)
08/2008